Kari Williams
Psychiatric/Mental Health · Gulfport, MSNPI 1932787421
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 196 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 14 manufacturers, the largest accounting for just 19.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $1,714 and has fallen 59.2% since, to $700 in 2025. Among psychiatric/mental health clinicians in MS with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 196 payments — averaging $22.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$837
- AbbVie$713
- Indivior Inc.$407
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$391
- Supernus Pharmaceuticals, Inc.$386
- Neurocrine Biosciences, Inc.$334
- plus $1K from 8 others
What the payments were for
- Food & beverage$4,343100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 52 | $837 |
| AbbVie | 38 | $713 |
| Indivior Inc. | 29 | $407 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 11 | $391 |
| Supernus Pharmaceuticals, Inc. | 1 | $386 |
| Neurocrine Biosciences, Inc. | 10 | $334 |
| Otsuka America Pharmaceutical, Inc. | 9 | $324 |
| Vanda Pharmaceuticals Inc. | 9 | $234 |
| Alkermes, Inc. | 11 | $204 |
| Teva Pharmaceuticals USA, Inc. | 11 | $196 |
| Lundbeck LLC | 8 | $145 |
| E.r. Squibb & Sons, L.L.C. | 3 | $82 |
| Gilead | 3 | $72 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,343 in reported general payments places this provider in the 90th percentile of 486 psychiatric/mental health providers in Mississippi.
See all psychiatric/mental health providers in Mississippi →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Invega SustennaPaliperidone Palmitate | 103 | $334,248 |
| Invega TrinzaPaliperidone Palmitate | 12 | $103,646 |
| Abilify MaintenaAripiprazole | 13 | $34,766 |
| Haloperidol Decanoate | 98 | $8,818 |
| Asenapine Maleate | 14 | $3,249 |
| Paliperidone ErPaliperidone | 24 | $2,424 |
| Clozapine | 19 | $2,283 |
| Divalproex Sodium ErDivalproex Sodium | 47 | $1,439 |
| Haloperidol | 53 | $1,324 |
| Quetiapine Fumarate ErQuetiapine Fumarate | 46 | $1,136 |
| Divalproex Sodium | 70 | $1,127 |
| Benztropine Mesylate | 97 | $999 |
| Olanzapine OdtOlanzapine | 25 | $781 |
| Olanzapine | 52 | $703 |
| Quetiapine Fumarate | 71 | $699 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonInvega Sustenna, Invega Trinza | $837 | $437,894115 claims |
| Otsuka America Pharmaceutical, Inc.Abilify Maintena | $324 | $34,76613 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 486 psychiatric/mental health providers in Mississippi.
Other psychiatric/mental health in Gulfport
- Desiree NormanGulfport$10K
- Tangular BarnesGulfport$9K
- Anita HallGulfport$8K
- Belinda HoldenGulfport$7K
- Chantal SullivanGulfport$7K
- Anne TuckerGulfport$5K
- Jo DrennanGulfport$4K
- Elizabeth GarrigaGulfport$4K
- Ashley KarelVicksburg$129K
- Amanda HamCorinth$64K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.